Inventor · disambiguated record
Yonghong Gan
Also filed as: GAN YONGHONG
4 granted patents·2 pending applications·45 citations·filing 2021–2025
75Inventor score
Top patents by PatentIndex Score
6 records- 0195US11427534B1Solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2021·Granted Aug 30, 2022·19 cites·6 claims
- 0295US11084780B1Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2021·Granted Aug 10, 2021·24 cites·15 claims
- 0394US11884610B2Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2022·Granted Jan 30, 2024·2 cites·6 claims
- 0485US12275688B2Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2024·Granted Apr 15, 2025·0 cites·20 claims
- 0572US2025270166A1Crystalline solids of mek inhibitor n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo--phenylamino)-benzamide and uses thereofSPRINGWORKS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0656US2024400558A1Processes and intermediates for synthesis of adagrasibMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yonghong Gan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →